Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04852029 · ClinicalTrials.gov registry record · NA
Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes
A NA study, sponsored by Reproductive Medicine Associates of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04852029 is a NA study that was terminated before completion, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 12 participants.
The verdict
NCT04852029, a NA study, was terminated before completion, sponsored by Reproductive Medicine Associates of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the effect of tailoring dosage of low-dose hCG secondary to serum hCG levels during IVF ovarian stimulation on sustained implantation rates of preimplantation genetically tested euploid embryos.
Interventions
- OTHER Low dose hCG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04852029
The ClinicalTrials.gov registry entry for NCT04852029 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low dose hCG is the first listed.
NCT04852029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04852029 about?
NCT04852029 is a clinical study titled "Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes". The purpose of the study is to determine the effect of tailoring dosage of low-dose hCG secondary to serum hCG levels during IVF ovarian stimulation on sustained implantation rates of preimplantation genetically tested euploid embryos.
What is the current status of trial NCT04852029?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2021-08-16. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04852029?
The interventions under investigation include: Low dose hCG (OTHER).
Who is sponsoring clinical trial NCT04852029?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.